AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data

Last updated: April 16, 2025
Sponsor: The Eye Hospital of Wenzhou Medical University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT06791499
AI-agent
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical study is to evaluate the effectiveness of an AI agent in diagnosing and predicting diseases using electronic health records (EHR) and multimodal imaging data. The AI agent leverages advanced machine learning algorithms to process and analyze diverse health data sources, aiming to assist healthcare providers in making more accurate diagnoses and predictions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Participants must have comprehensive electronic health records (EHR) available,including demographic information, medical history, and laboratory results.

  2. Participants must have available multimodal imaging data (e.g., X-rays, CT scans,MRIs, ultrasounds) relevant to their health condition.

  3. Participants must have a confirmed diagnosis of one or more diseases or healthconditions based on clinical records or imaging data.

  4. Patients must provide consent for the use of their historical health data forresearch purposes.

Exclusion

Exclusion Criteria:

  1. Participants with ambiguous or unverifiable diagnoses that cannot be accuratelycategorized.

  2. Duplicate or redundant patient data (e.g., repeated records of the same patientwithout clear differentiation).

Study Design

Total Participants: 2000000
Study Start date:
July 01, 2023
Estimated Completion Date:
July 31, 2025

Study Description

This multi-center, retrospective clinical study is designed to evaluate the application and effectiveness of an AI agent in the medical decision-making process. The AI agent integrates and analyzes multimodal data, including electronic health records (EHR) and various imaging data (e.g., X-rays, MRIs, CT scans, ultrasounds) to predict and diagnose a range of diseases. By leveraging the power of machine learning and data fusion techniques, the AI agent can identify patterns in large and complex datasets, offering insights that may not be immediately apparent through traditional diagnostic methods.The study will compare the AI agent's diagnostic accuracy and disease prediction capabilities with traditional diagnostic practices to assess its potential benefits in clinical settings. Key questions include whether the AI agent can assist in early diagnosis, predict disease progression, and support healthcare professionals in making personalized treatment decisions. Participants will not be required to undergo any additional interventions; they will only provide historical health data, including EHR and relevant imaging data, which will be analyzed by the AI agent. The AI system will then use this data to assist healthcare providers by offering predictions and diagnostic suggestions based on the analysis of the multimodal information. The ultimate goal is to determine whether this AI-driven approach can improve diagnostic accuracy, optimize treatment strategies, and enhance patient outcomes in clinical practice.

Connect with a study center

  • Nanfang Hospital

    Guangzhou, Guangdong
    China

    Active - Recruiting

  • Sun Yat-Sen Memorial Hospital

    Guangzhou, Guangdong
    China

    Active - Recruiting

  • Sun Yat-sen University Cancer Hospital

    Guangzhou, Guangdong
    China

    Active - Recruiting

  • West China Hospital

    Chengdu, Sichuan
    China

    Active - Recruiting

  • First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang
    China

    Active - Recruiting

  • Second Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.